Will CoreWeave’s 400-Megawatt Lease Deal Reshape Applied Digital’s (APLD) Concentrated Revenue Narrative

• Applied Digital recently advanced its build-and-lease model for high-performance data centers, including a previously announced 400-megawatt campus leased to CoreWeave that is expected to underpin lease revenue as new facilities come online.
• An interesting angle is how these large, long-term hyperscale leases concentrate revenue in a few key customers, heightening both cash flow visibility and client risk.
• We’ll now explore how the CoreWeave 400-megawatt lease and broader campus monetization progress could reshape Applied Digital’s existing investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 20 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Applied Digital Investment Narrative Recap

To own Applied Digital, you need to believe its pivot to long-term AI and HPC data center leases can eventually outweigh current losses, heavy capex, and customer concentration. The CoreWeave 400 megawatt lease strengthens the case for future contracted revenue, but it also sharpens the main near term risk: execution and dependence on a small group of hyperscale clients. If project timelines slip or a key tenant stumbles, the impact on cash flow could be material.

Among recent announcements, the November 2025 milestone that brought Polaris Forge 1’s first 100 megawatts “ready for service” stands out. That step moved a portion of Applied Digital’s US$16 billion contracted revenue closer to actual billing and cash generation, directly tied to the same build and lease model behind the CoreWeave campus. Together, this news and the Polaris Forge progress frame the next 18 to 24 months as a crucial test of Applied Digital’s ability to turn signed contracts into operating assets.

Yet behind the growth headlines, investors should also weigh how rising debt and customer concentration could quickly magnify any setback in...

Read the full narrative on Applied Digital (it's free!)

Applied Digital's narrative projects $755.7 million revenue and $102.2 million earnings by 2028.

Uncover how Applied Digital's forecasts yield a $45.27 fair value, a 69% upside to its current price.

Exploring Other Perspectives

The most bearish analysts already expected Applied Digital to reach about US$777.5 million in revenue and US$19.9 million in earnings by 2028, yet they still view today’s risks like supply chain strain and technology churn as serious enough to justify a much lower fair value; with the CoreWeave build and new AI campuses evolving, it is worth asking whether those cautious assumptions still fit or if the story is starting to look different.

Explore 24 other fair value estimates on Applied Digital - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Applied Digital research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free Applied Digital research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Applied Digital's overall financial health at a glance.

Interested In Other Possibilities?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• AI is about to change healthcare. These 36 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com